Comparison of 1 year versus minimum 2 years of anti-PD1-based immunotherapy as first-line treatment for metastatic melanoma: Results of the DANTE phase III trial

No Thumbnail Available

All Authors

Danson,Sarah
Collinson,Michelle
Plummer,Elizabeth Ruth
Ottensmeier,Christian H. H.
Silva,Shobha
Hook,Jane
Hapuarachi,Brindley Sonal
Wheater,Matthew
Payne,Miranda
Oladipo,Olabode
Show 10 more

LTHT Author

Hook, Jane

LTHT Department

Leeds Cancer Centre
Oncology

Non Medic

Publication Date

2025

Item Type

Article

Language

Subject

Subject Headings

Abstract

Journal

Journal of Clinical Oncology

URI

https://hdl.handle.net/20.500.14838/2863

DOI

10.1200/JCO.2025.43.17_suppl.LBA9508

Collections

External Publications